Amalgamated Bank’s ClearPoint Neuro CLPT Stock Holding History

Amalgamated Bank’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-827	Closed	-$11K	–	1873
2025 Q4	$11K	Sell	827 -63	-7%	-$1.17K	﹤0.01%	2365
2025 Q3	$19K	Hold	890	–	–	﹤0.01%	2141
2025 Q2	$11K	Buy	+890	New	+$11.2K	﹤0.01%	2388
2024 Q2	–	Sell	-773	Closed	-$5K	–	3030
2024 Q1	$5K	Sell	773 -2,398	-76%	-$16.8K	﹤0.01%	2703
2023 Q4	$22K	Sell	3,171 -230	-7%	-$1.3K	﹤0.01%	2598
2023 Q3	$17K	Hold	3,401	–	–	﹤0.01%	2722
2023 Q2	$25K	Buy	+3,401	New	+$28.9K	﹤0.01%	2623
2022 Q2	–	Sell	-3,111	Closed	-$32K	–	3061
2022 Q1	$32K	Buy	+3,111	New	+$28.3K	﹤0.01%	2650

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Amalgamated Bank's CLPT Position: Q1 2026 in Review

Amalgamated Bank sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 827 shares — an estimated $11K sold.

Amalgamated Bank first reported a position in CLPT in Q1 2022 and held it in 8 quarters. The position peaked at $32K in Q1 2022. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

Amalgamated Bank reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
Amalgamated Bank sold 827 ClearPoint Neuro shares in Q1 2026, an estimated $11K.
Amalgamated Bank first reported a position in ClearPoint Neuro in Q1 2022 and held it in 8 quarters.
Amalgamated Bank's ClearPoint Neuro position peaked at $32K in Q1 2022.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.